PER 2.35% 8.7¢ percheron therapeutics limited

Ann: Positive PDCO opinion and A$20m Placement, page-61

  1. 4,683 Posts.
    lightbulb Created with Sketch. 1086
    In the Biotech realm - we are on the home stretch....seriously.

    A 'pivotal' trial with 'Futility' results mid 2023.

    Hint to future activities is the appointment of Prof Voit as PI for Phase 2II/3.

    I will be very surprised if we are here talking about commercialization....

    Lets see how we go.
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢
Change
0.002(2.35%)
Mkt cap ! $78.43M
Open High Low Value Volume
8.6¢ 8.9¢ 8.5¢ $53.40K 614.3K

Buyers (Bids)

No. Vol. Price($)
1 49999 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 67263 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.